Evidence map›Paper›PMID 39274840›Full record

ArticleMolecules (Basel, Switzerland)2024

Differences in the Renal Accumulation of Radiogallium-Labeled (Glu)

Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Masayuki Munekane, Takeshi Fuchigami, Hiroaki Echigo, Hiroshi Wakabayashi, Seigo Kinuya

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kazuma OgawaInstitute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.ORCID 0000-0002-1691-7302
Kota NishizawaGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.
Kenji MishiroInstitute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.ORCID 0000-0002-5071-7574
Masayuki MunekaneGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.ORCID 0000-0002-3405-4512
Takeshi FuchigamiGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.
Hiroaki EchigoGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Ishikawa, Japan.
Hiroshi WakabayashiDepartment of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8641, Ishikawa, Japan.
Seigo KinuyaDepartment of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8641, Ishikawa, Japan.

Funding

JSPS KAKENHI 15K09948Nakatomi Foundation NoSagawa Foundation for Promotion of Cancer Research NoTerumo Life Science Foundation No
6 · The paper itself

Abstract

Acidic amino acid peptides have a high affinity for bone. Previously, we demonstrated that radiogallium complex-conjugated oligo-acidic amino acids possess promising properties as bone-seeking radiopharmaceuticals. Here, to elucidate the effect of stereoisomers of Glu in Glu-containing peptides [(Glu)

Indexed as

Gallium RadioisotopesGlutamic AcidKidneyPeptidesRadiopharmaceuticalsAnimalsBone and BonesMiceTissue DistributionGallium RadioisotopesGlutamic AcidPeptidesRadiopharmaceuticalsbone imagingbone metastasesgalliumglutamic acidkidney accumulation

Identifiers

PMID39274840
PMCPMC11396517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.